|
IARS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.292200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.459580E-02 |
| Normal-vs-Stage2 |
9.491000E-01 |
| Normal-vs-Stage3 |
8.202400E-01 |
| Normal-vs-Stage4 |
4.046600E-01 |
| Stage1-vs-Stage2 |
3.187800E-01 |
| Stage1-vs-Stage3 |
3.027200E-01 |
| Stage1-vs-Stage4 |
6.413700E-02 |
| Stage2-vs-Stage3 |
9.188400E-01 |
| Stage2-vs-Stage4 |
3.500400E-01 |
| Stage3-vs-Stage4 |
3.832200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.402100E-02 |
| Normal-vs-AfricanAmerican |
1.526570E-01 |
| Normal-vs-Asian |
8.473400E-01 |
| Caucasian-vs-AfricanAmerican |
8.027200E-01 |
| Caucasian-vs-Asian |
9.139000E-01 |
| AfricanAmerican-vs-Asian |
8.425800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.628200E-04 |
| Normal-vs-Female |
1.130630E-01 |
| Male-vs-Female |
1.020620E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.406800E-01 |
| Normal-vs-Extreme_Weight |
4.07179999994955E-06 |
| Normal-vs-Obese |
7.721000E-01 |
| Normal-vs-Extreme_Obese |
1.000960E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.771600E-02 |
| Normal_Weight-vs-Obese |
6.530200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.278000E-01 |
| Extreme_Weight-vs-Obese |
1.470140E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.656800E-01 |
| Obese-vs-Extreme_Obese |
2.512000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.412400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.037400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.637600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.794000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.136000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.248200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.510430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.819600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.230800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.579800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.12940000005246E-06 |
| Normal-VS-Type2 PRCC |
6.210400E-01 |
| Normal-VS-KIRP CIMP |
9.914100E-02 |
| Normal-VS-Unclassified PRCC |
9.657200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.319500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.334300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.127630E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.253410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.738000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.023220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.298390E-02 |
| Normal-vs-N1 |
2.755400E-01 |
| Normal-vs-N2 |
6.357600E-01 |
| N0-vs-N1 |
5.885500E-02 |
| N0-vs-N2 |
4.721600E-01 |
| N1-vs-N2 |
8.481600E-01 |
|
|
